Patients with classical Hodgkin lymphoma (cHL) typically receive first-line chemotherapy or chemoradiotherapy, and cure rates are high [1]. However, some patients may have primary refractory cHL, c...
No takes yet. Share an insight, caveat, or question.
Zinzani et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: